Abstract:Aim: To detect the level of thyroid hormone in patients with major depressive disorder and dysthymic disorder, and observe the biological significance of neuroendocrine changes in the patients with major depressive disorder and dysthymic disorder. Methods: Inpatients with major depressive disorder (n=30) and dysthymic disorder (n=30) were selected from the outpatient departments of psychiatry and neurology and the third inpatient division of the Department of Psychiatry, the First Clinical Hospital of Harbin Medical University, and Harbin First Specific Hospital between January and December 2004. They were assessed with Hamilton depression scale (HAMD), Eysenck personality questionnaire (EPQ) and life event scale (LES). The serum levels of 3,5,3-triiodothyronine (T 3), 3,5,3,5,-tetraiodotyyronine (T 4) and thyroid stimulating hormone (TSH) were determined with radioimmunoassay in both groups. Results: All the 30 patients with major depressive disorder and 30 patients with dysthymic disorder entered the analysis of results. 1 The total score of HAMD had completely significant difference between the groups (P=0.000), and there were significant differences in the factor scores of anxiety/somatization, cognitive impairment and retardation, and the neural scale in EPQ (P < 0.05). 2 The T 4 level was significantly different between the two groups. 3 In the patients with major depressive disorder, the T 3 level was positively correlated with the score of extraversion-introversion in EQP and the score of retardation in HAMD (r=0.0411, 0.426, P=0.024, 0.019); T 4 level was positively correlated with the total score of HAMD, score of anxiety, and the stimulative amount of negative life events (r=0.474, 0.416, 0.426, P=0.015, 0.022, 0.019); TSH was positively correlated with the stimulative amount of positive life events (r=0.433, P=0.017). In the patients with dysthymic disorder, T 3 level was negative correlated with the score of cognitive impairment (r=-0.509, P=0.004); T 4 level had positive correlation with the total score of HAMD, stimulative amount of negative life events and score of retardation (r=0.396, 0.420, 0.367, P=0.042, 0.021, 0.046). Conclusion: Negative life events accelerate the episode of depression, and T 4 level could be a useful predictor for the severity of depressive symptoms.

Study on Serum Levels of Cortisol and Prolactin Between Depressive Female in Patients

Gender Differences of Schizophrenia Patients with and Without Depressive Symptoms in Clinical Characteristics.

The Association Between Prolactin Levels and Cognitive Function in Female Patients With Severe Mental Disorders

The Changes In, and Relationship Between, Plasma Nitric Oxide and Corticotropin‐releasing Hormone in Patients with Major Depressive Disorder

A study on the correlations of PRL levels with anxiety, depression, sleep, and self-efficacy in patients with prolactinoma

Gender differences in the influence of escitalopram on prolac-tin levels in patients with first-episode depression

Changes of Serum Melatonin, Interleukin-6, Homocysteine, and Complement C3 and C4 Levels in Patients With Depression

An Initial Exploration of Hair Cortisol Responses to Antidepressants in Unmedicated Patients with Depression

Correlation Between the Plasma Cortisol Level and the Characteristics of Magnetic Resonance Spectroscopy of the Prefrontal Cortex and Hippocampus in Depressed Patients

Ndt_a_333154 3483..3488

Testosterone and Prolactin Perturbations Possibly Associated with Reduced Levels of β-Arrestin1 in Mononuclear Leukocytes of Women with Premenstrual Dysphoric Disorder

Study on the changes of thyroid hormone levels in patients with perimenopausal depressive episode

Sex differences in cortisol levels in depression: A systematic review and meta-analysis

Comparison of the level of thyroid hormones between patients with major depressive disorder and dysthymic disorder

Study on the level and relative factors of serum uric acid in the patients with depressive episodes of bipolar I disorder

Comparisons of Serum Interleukin-8 Levels in Major Depressive Patients With Drug-Free Versus SSRIs Versus Healthy Controls

Study on the level of free thyroxin in first-episode depressions with varied severity

Study of decreased serum levels of C1q/TNF-related protein 4 (CTRP4) in major depressive disorder

The relationship between serum prolactin levels and cognitive function in drug-naïve schizophrenia patients: a cross-sectional study

Associations between Sex Hormones and Circulating Growth Differentiation Factor-15 in Male Patients with Major Depressive Disorder